Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes

European Heart Journal

Volumn 25, Issue 9, 2004, Pages 709-711

  Gami, Apoor S ^a   Somers, Virend K ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN;

BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; HUMAN; HYPERCOAGULABILITY; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICROALBUMINURIA; MORBIDITY; MORTALITY; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK FACTOR; SLEEP APNEA SYNDROME; SYMPATHETIC TONE;

CORONARY ARTERIOSCLEROSIS; HUMANS; METABOLIC SYNDROME X; PROGNOSIS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 2442419626     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.03.008     Document Type: Editorial

References (10)

1. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003;290: 1906-14.
2. Reaven G. Metabotic syndrome: Pathophysiology and implications for management of cardiovascular disease. Circulation 2002;106: 286-8.
3. Wilcox I, McNamara SG, Collins FL et al. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53(Suppl 3):S25-8.
4. Coughlin S. Mawdstey, L., Mugarza, JA et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-41.
5. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359: 204-10.
6. Harsch IA, Pour Schahin S, Radespiel-Troger M et al. CPAP treatment rapidly improves insulin sensitivity in patients with OSAS. Am J Respir Crit Care Med 2003.
7. Milleron, O, Pillière R, Foucher A et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:728-34.
8. Narkiewicz K, Kato M, Phillips BG et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999;100:2332-5.
9. Mooe T, Franklin KA, Holmstrom K et al. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001;164:1910-3.
10. Peker Y, Hedner J, Kraiczi H et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-6.